UWMDI Co-Director Michael Schwartz, MD, is co-author of “Transcriptomic Analysis Links the Response of Diverse Hypothalamic Cell Types to Sustained Diabetes Remission Induced by Fibroblast Growth Factor 1,” which has
Read MoreUWMDI Investigator, Carlos Campos, PhD, published in Nature Communications, titled “Organ-specific, multimodal, wireless optoelectronics for high-throughput phenotyping of peripheral neural pathways”. Read article here
Read MoreUWMDI Acting Instructor of Medicine, Jennifer Deem, PhD, is a first author on a manuscript entitled “Cold-induced hyperphagia requires AgRP-neuron activation in mice” in the journal Elife that also includes
Read MoreUWMDI Investigator Dr. Vincenzo Cirulli, MD, PhD, coauthors new study published in Developmental Cell identifying the myelin regulatory factor (MYRF) as an important ER membrane-associated transcription factor that promotes the
Read MoreUWMDI Investigator Dr. Vincenzo Cirulli, MD, PhD, has been elected to the Board of Directors of the Diabetes Research Connection (https://diabetesresearchconnection.org/), a non-profit organization devoted to support early-career scientists to perform
Read MoreNew LatinX Diabetes Clinic Featured on Kiro7 News, “Western Washington Gets Real: A critical lack of Latina doctors” Read Article
Read MoreUWMDI Co-Director Stephanie Page, MD, PhD, is quoted in “‘Creativity Is Simply Lost’ as Covid Cripples Academic Research” from Bloomberg Government.
Read MoreUWMDI investigator Dr. Alan Chait is senior author of “Serum amyloid A–containing HDL binds adipocyte-derived versican and macrophage-derived biglycan, reducing its antiinflammatory properties” in JCI Insight.
Read MoreRead article in English Read article in Spanish
Read MoreThe LatinX community is the largest and fastest growing minority group in the state of Washington and the country. LatinX individuals are disproportionately affected by diabetes. Diabetes affects the LatinX
Read More